Diffusion Pharmaceuticals CEO David Kalergis' 2018 pay rises 15% to $587K
Diffusion Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 30, 2019
Diffusion Pharmaceuticals reported fiscal year 2018 executive compensation information on April 30, 2019.
In 2018, four executives at Diffusion Pharmaceuticals received on average a compensation package of $468K, a 36% increase compared to previous year.
Average pay of disclosed executives at Diffusion Pharmaceuticals
David G. Kalergis, Chief Executive Officer, received $587K in total, which increased by 15% compared to 2017. 75% of Kalergis' compensation, or $439K, was in salary. Kalergis also received $66K in non-equity incentive plan, $65K in option awards, as well as $17K in other compensation.
John L. Gainer, Chief Scientific Officer, received a compensation package of $507K, which increased by 13% compared to previous year. 73% of the compensation package, or $370K, was in salary.
Ben L. Shealy, Secretary, earned $408K in 2018, a 41% increase compared to previous year.
William K. Hornung, Chief Financial Officer, received $371K in 2018, which increases by 186% compared to 2017.
Related executives
You may also like
Source: SEC filing on April 30, 2019.